| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/05/2014 | CN103619877A Modified variable domain molecules and methods for producing and using them b |
| 03/05/2014 | CN103614443A Method for extracting biological active peptide from marine aquatic product |
| 03/05/2014 | CN103614442A Method for promoting hydrolysis of chicken blood to prepare polypeptide |
| 03/05/2014 | CN103614441A Preparation method of high-purity parathyroid hormone for medical detection |
| 03/05/2014 | CN103614440A Fusion protein identification method |
| 03/05/2014 | CN103614439A Protein separating and enriching method |
| 03/05/2014 | CN103614438A Actinomycete metabolite and inhibitor prepared therefrom |
| 03/05/2014 | CN103614381A Chicken beta-defensin AvBD6 gene and construction method of lactics carrier of same |
| 03/05/2014 | CN103614380A Preparation and expression method of chicken beta-defensin 9 yeast engineered bacteria |
| 03/05/2014 | CN103614340A Cell line for stable expression of chicken interleukin 10 protein, as well as construction method and application thereof |
| 03/05/2014 | CN103611154A Lophius litulon skin collagen peptide composition capable of resisting gram negative bacteria |
| 03/05/2014 | CN103233053B Production method for recombinant human granulocyte colony-stimulating factor |
| 03/05/2014 | CN103205478B Method for industrially producing recombinant human erythropoietin |
| 03/05/2014 | CN102676622B Andrias davidianus nano peptide and andrias davidianus wine |
| 03/05/2014 | CN102634524B Cell expansion lethal toxin and detection of bacterium belonging to campylobacter genus that targets same |
| 03/05/2014 | CN101899098B Preparation of cyclic lipopeptide compound Maribasin B and application thereof |
| 03/05/2014 | CN101631802B Anti-human Dlk-1 antibody showing anti-tumor activity in vivo |
| 03/04/2014 | US8664367 IL-I binding proteins |
| 03/04/2014 | US8664366 Fusion proteins forming trimers |
| 03/04/2014 | US8664365 Antibodies to EphA3 |
| 03/04/2014 | US8664362 Humanized and chimeric anti-properdin antibodies |
| 03/04/2014 | US8664360 BSL3 polypeptides |
| 03/04/2014 | US8663989 Retroviral vector particles and methods for their generation and use |
| 03/04/2014 | US8663980 Vectors, host cells, and methods of production and uses |
| 03/04/2014 | US8663971 Protein glycosylation modification in methylotrophic yeast |
| 03/04/2014 | US8663950 Production of a monoclonal antibody therapeutic against west nile virus in plants |
| 03/04/2014 | US8663948 Host, transformant and method for producing the transformant and method for producing O-glycosylated heterologous protein |
| 03/04/2014 | US8663945 Methods of producing anti-TNF-alpha antibodies in mammalian cell culture |
| 03/04/2014 | US8663936 Sodium channel protein type III α-subunit splice variant |
| 03/04/2014 | US8663933 Recombinant protein capable of binding specifically and quickly to troponin I derived from human myocardium |
| 03/04/2014 | US8663916 Methods for producing antifungal bifunctional molecules for treating fungal infection |
| 03/04/2014 | US8663629 Kallikrein-binding “kunitz domain” proteins and analogues thereof |
| 03/04/2014 | US8663598 Anti-human transferrin receptor antibody and uses thereof |
| 02/27/2014 | WO2014032021A1 Antibody drug conjugates (adc) that bind to 158p1d7 proteins |
| 02/27/2014 | WO2014030726A1 Protein production accelerator |
| 02/27/2014 | WO2014030641A1 Support for cell culture and method for producing protein or peptide using cultured cells |
| 02/27/2014 | WO2014030597A1 Novel compound and method for producing same, novel microorganism, pharmaceutical composition, and anti-tumor agent |
| 02/27/2014 | WO2014005019A3 Cells for producing recombinant iduronate-2-sulfatase |
| 02/27/2014 | WO2013170272A3 Site-specific labeling and targeted delivery of proteins for the treatment of cancer |
| 02/27/2014 | WO2013170017A3 Enzyme-based protein separation and enrichment from soy meal, wheat meal, and other protein-rich materials derived from plant seeds, fruits and other biomass |
| 02/27/2014 | WO2013009545A8 Engineered polypeptides having enhanced duration of action with reduced immunogenicity |
| 02/27/2014 | US20140058790 Deuterated peptides |
| 02/27/2014 | US20140057999 Protective, hydrocolloid for active ingredients |
| 02/27/2014 | US20140057971 LaFORA'S DISEASE GENE |
| 02/27/2014 | US20140057317 Evolution of bond-forming enzymes |
| 02/27/2014 | US20140056921 Hepatocyte Growth Factor Receptor Antagonists and Uses Thereof |
| 02/26/2014 | EP2700652A1 Diagnosis and treatment of cancer using anti-itm2a antibody |
| 02/26/2014 | EP2700399A1 Drug delivery particles and method for producing same |
| 02/26/2014 | EP2699689A1 Streptococcus bacteriophage lysins for treatment of gram positive bacteria in companion animals and livestock |
| 02/26/2014 | EP2699597A1 Modified variable domain molecules and methods for producing and using them b |
| 02/26/2014 | CN103608464A Clostridium difficile antigens |
| 02/26/2014 | CN103608463A Method for preparing polymeric protein composed of monomeric protein produced by fusing protein having immunoglobulin fold structure to protein capable of serving as subunit structure |
| 02/26/2014 | CN103608358A Monoclonal antibody for acetylamantadine |
| 02/26/2014 | CN103603197A Method for improving dyeing property of superfine fiber synthetic leather base cloth |
| 02/26/2014 | CN103602713A Method for promoting pig blood hydrolysis |
| 02/26/2014 | CN103602712A Method for preparing active protein peptide from cold pressing tea cake |
| 02/26/2014 | CN103602616A Bacillus amyloliquefaciens Y10 and application thereof |
| 02/26/2014 | CN103601802A Method for promoting fishbone hydrolysis utilization |
| 02/26/2014 | CN103601801A Method of promoting extraction of fishskin collagen |
| 02/26/2014 | CN103039495B Jiang chuan mycin for preventing and controlling plant diseases |
| 02/26/2014 | CN102766671B Method for extracting proteins from vitamin C fermented mash |
| 02/26/2014 | CN102277407B Method for preparing anticoagulant leech peptide by enzymolysis |
| 02/26/2014 | CN101003573B Human antibodies that bind human tnfalpha |
| 02/25/2014 | US8658766 Soluble hybrid Fcγ receptors and related methods |
| 02/25/2014 | US8658602 Multimeric constructs |
| 02/25/2014 | US8658598 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies |
| 02/25/2014 | US8658409 Polypeptides having acetyl xylan esterase activity and polynucleotides encoding same |
| 02/25/2014 | US8658406 EGVII endoglucanase and nucleic acids encoding the same |
| 02/25/2014 | US8658400 Biocatalysts for manufacturing duloxetine alcohol |
| 02/25/2014 | US8658396 Screening method for protein variants using mass spectrometry |
| 02/25/2014 | US8658395 Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells |
| 02/25/2014 | US8658394 Methods, cells and systems for incorporating non-canonical amino acids into proteins |
| 02/25/2014 | US8658386 Hybridomas producing highly specific monoclonal antibodies to detect mycobacterium avium subspecies paratuberculosis |
| 02/25/2014 | US8658178 Carbon nanotube compositions and methods of use thereof |
| 02/25/2014 | US8658166 Methods and materials for the diagnosis of prostate cancers |
| 02/25/2014 | US8658164 Methods and materials for the diagnosis of prostate cancers |
| 02/25/2014 | CA2788707C Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| 02/25/2014 | CA2720980C Methods for enhanced production of bone morphogenetic proteins |
| 02/25/2014 | CA2564831C Method of forming disulfide crosslink in in vitro protein synthesis |
| 02/25/2014 | CA2538252C 4'-thionucleosides and oligomeric compounds |
| 02/25/2014 | CA2376665C Novel tet repressor-based transcriptional regulatory proteins |
| 02/20/2014 | WO2014028833A1 Methods for co-silencing expression of genes in filamentous fungal strains and uses thereof |
| 02/20/2014 | WO2014028502A1 Engineered antibody-interferon fusion molecules for treatment of autoimmune diseases |
| 02/20/2014 | WO2014028451A1 Optogenetic control of endothelial cells |
| 02/20/2014 | WO2014027698A1 Anti-staphylococcus aureus capsular polysaccharide monoclonal antibody |
| 02/20/2014 | WO2014027697A1 Anti-pneumococcal surface protein (psp) monoclonal antibody |
| 02/20/2014 | WO2014027626A1 MONOCLONAL IgE ANTIBODY BONDING TO SWEAT ALLERGY ANTIGEN PROTEIN |
| 02/20/2014 | WO2014027473A1 Stable isotope-labeled aliphatic amino acid and nmr structural analysis of protein using same |
| 02/20/2014 | WO2013108044A8 Norbornene modified peptides and their labelling with tetrazine compounds |
| 02/20/2014 | WO2012149365A3 Antibodies selective for pathological tau dimers and oligomers and their uses in treatment, diagnosis, monitoring of tauopathies |
| 02/20/2014 | US20140051835 Process and Methods for Efficient Manufacturing of Highly Pure Asymmetric Antibodies in Mammalian Cells |
| 02/20/2014 | US20140051124 Methods for reducing accumulation of lactate during culturing and method for producing polypeptide |
| 02/20/2014 | US20140051123 Method of increasing the productivity of eucaryotic cells in the production of recombinant fviii |
| 02/20/2014 | US20140051121 Feed mixing device and its use |
| 02/20/2014 | US20140051093 High level expression of recombinant toxin proteins |
| 02/19/2014 | EP2698386A1 Fusion protein |
| 02/19/2014 | EP2697387A2 Chimeric antibacterial polypeptides |
| 02/19/2014 | EP2697386A2 Pepducin design and use |
| 02/19/2014 | EP2697385A1 Fermentation process |
| 02/19/2014 | EP2697258A1 Compositions and methods for the alteration of xlhed phenotypes |